InvestSMART

Medical Developments International Limited (ASX: MVP) - Announcements

- Current share price for MVP : $0.480

ASX company news and announcements for Medical Developments International Limited (MVP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medical Developments International Limited (MVP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medical Developments International Limited (MVP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medical Developments International Limited (MVP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$54 Change of Director's Interest Notice 16 Oct 2017 8:24AM $5.730 $0.480 fallen by 91.62%
$54 Chairman sells 4.35 million shares 16 Oct 2017 8:24AM $5.730 $0.480 fallen by 91.62%
$54 Change of Director's Interest Notice 6 Oct 2017 11:47AM $5.390 $0.480 fallen by 91.09%
$54 Appendix 3B 6 Oct 2017 11:46AM $5.390 $0.480 fallen by 91.09%
$54 Penthrox recommended for use in all UK ambulances 26 Sep 2017 3:34PM $4.990 $0.480 fallen by 90.38%
$54 Notice of Annual General Meeting/Proxy Form 21 Sep 2017 2:35PM $5.040 $0.480 fallen by 90.48%
$54 Annual Report to shareholders 21 Sep 2017 11:33AM $5.040 $0.480 fallen by 90.48%
$54 Update - Dividend/Distribution - MVP 6 Sep 2017 9:55AM $5.050 $0.480 fallen by 90.50%
$54 Update - Dividend/Distribution - MVP 18 Aug 2017 4:40PM $5.150 $0.480 fallen by 90.68%
$54 Appendix 4G 18 Aug 2017 9:38AM $5.150 $0.480 fallen by 90.68%
$54 Preliminary Final Report and Full Year Accounts 18 Aug 2017 9:37AM $5.150 $0.480 fallen by 90.68%
$54 CEO Roadshow Presentation 18 Aug 2017 12:22AM $5.000 $0.480 fallen by 90.40%
$54 Dividend/Distribution - MVP 18 Aug 2017 12:17AM $5.040 $0.480 fallen by 90.48%
$54 1st patient enrolled in Penthrox paediatrics trial in Europe 16 Aug 2017 2:30PM $5.100 $0.480 fallen by 90.59%
$54 MVP signs Respiratory Device supply deal with Sams Club 2 Aug 2017 3:08PM $5.060 $0.480 fallen by 90.51%
$54 Appendix 3B 3 Jul 2017 2:00PM $4.970 $0.480 fallen by 90.34%
$54 Penthrox Regulatory Dossier accepted for review in Canada 15 Jun 2017 10:21AM $5.390 $0.480 fallen by 91.09%
$54 Presentation at Jefferies 2017 Global Healthcare Conference 8 Jun 2017 10:48AM $5.220 $0.480 fallen by 90.80%
$54 MVP signs significant Development Project with CSIRO 5 Jun 2017 8:39AM $5.070 $0.480 fallen by 90.53%
$54 Penthrox replaces Nitrous Oxide in New Zealand Ambulance 2 Jun 2017 8:24AM $4.800 $0.480 fallen by 90%
$54 MVP Respiratory devices now available in USA Costco's 27 Apr 2017 8:26AM $4.750 $0.480 fallen by 89.89%
$54 Penthrox Licensing Deal for Russia 12 Apr 2017 8:32AM $4.950 $0.480 fallen by 90.30%
$54 Change of Director's Interest Notices 11 Apr 2017 8:28AM $5.000 $0.480 fallen by 90.40%
$54 Appendix 3B 11 Apr 2017 8:28AM $5.000 $0.480 fallen by 90.40%
$54 MVPs Respiratory Devices in all Kmart pharmacies in the USA 10 Apr 2017 1:43PM $5.040 $0.480 fallen by 90.48%

426 - 450 of 615 results

Page 18 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.